Zacks Investment Research
16 Jun 2026, 22:51 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
Procter & Gamble currently holds a Zacks Rank of #4 (Sell). — A 'Sell' rating from a major research provider suggests a negative outlook on near-term price performance based on estimate revisions.
-0.40The projected EPS for P&G's upcoming quarter is $1.44, representing a 2.70% decrease compared to the previous year. — A projected decline in earnings per share typically puts downward pressure on a stock's valuation.
-0.30Procter & Gamble's Forward P/E ratio of 21.79 is at a premium compared to its industry average of 19.48. — Trading at a premium to the industry average can make a stock less attractive to value investors and increase the risk of a correction.
-0.20Continue reading
6 related stories
Top 1 mover · tap to explore
Consensus estimates project P&G's revenue for the upcoming quarter to be $21.46 billion, a 2.74% increase year-over-year. — Slight revenue growth is a positive sign of business stability, though modest in magnitude.
Which stocks this story touches
The company has a Zacks Rank of #4 (Sell) and projected EPS is expected to drop compared to the previous year.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
1h ago
